RESUMEN

The human foot is uniquely adapted to bipedal locomotion and has a deformable arch of variable stiffness. Intrinsic foot muscles regulate arch deformation, making them important for foot function. In this study we explore the hypothesis that normal daily activity in minimal footwear, which provides little or no support, increases foot muscle strength. Western adults wore minimal footwear for a six-month period (the "intervention" group). Foot strength, i.e., maximum isometric plantarflexion strength at the metatarsophalangeal joints, and foot biometrics were measured before and after the intervention. An additional group was investigated to add further insight on the long-term effects of footwear, consisting of Western adults with an average 2.5 years of experience in minimal footwear (the "experienced" group). This study shows that foot strength increases by, on average, 57.4% (p < 0.001) after six months of daily activity in minimal footwear. The experienced group had similar foot strength as the post intervention group, suggesting that six months of regular minimal footwear use is sufficient to gain full strength, which may aid healthy balance and gait.

Asunto(s)

Pie/fisiología , Fuerza Muscular/fisiología , Zapatos/efectos adversos , Adulto , Fenómenos Biomecánicos , Femenino , Marcha/fisiología , Humanos , Locomoción , Masculino , Músculo Esquelético/fisiología , Carrera/fisiología

RESUMEN

The endonuclease Artemis is responsible for opening DNA hairpins during V(D)J recombination and for processing a subset of pathological DNA double-strand breaks. Artemis is an attractive target for the development of therapeutics to manage various B cell and T cell tumors, because failure to open DNA hairpins and accumulation of chromosomal breaks may reduce the proliferation and viability of pre-T and pre-B cell derivatives. However, structure-based drug discovery of specific Artemis inhibitors has been hampered by a lack of crystal structures. Here, we report the structure of the catalytic domain of recombinant human Artemis. The catalytic domain displayed a polypeptide fold similar overall to those of other members in the DNA cross-link repair gene SNM1 family and in mRNA 3'-end-processing endonuclease CPSF-73, containing metallo-ß-lactamase and ß-CASP domains and a cluster of conserved histidine and aspartate residues capable of binding two metal atoms in the catalytic site. As in SNM1A, only one zinc ion was located in the Artemis active site. However, Artemis displayed several unique features. Unlike in other members of this enzyme class, a second zinc ion was present in the ß-CASP domain that leads to structural reorientation of the putative DNA-binding surface and extends the substrate-binding pocket to a new pocket, pocket III. Moreover, the substrate-binding surface exhibited a dominant and extensive positive charge distribution compared with that in the structures of SNM1A and SNM1B, presumably because of the structurally distinct DNA substrate of Artemis. The structural features identified here may provide opportunities for designing selective Artemis inhibitors.

Asunto(s)

Endonucleasas/química , Pliegue de Proteína , Zinc/química , Animales , Dominio Catalítico , Proteínas de Unión al ADN , Endonucleasas/genética , Humanos , Células Sf9 , Spodoptera , Relación Estructura-Actividad

RESUMEN

Ghrelin influences a variety of metabolic functions through a direct action at its receptor, the GhrR (GhrR-1a). Ghrelin knockout (KO) and GhrR KO mice are resistant to the negative effects of high-fat diet (HFD) feeding. We have generated several classes of small-molecule GhrR antagonists and evaluated whether pharmacologic blockade of ghrelin signaling can recapitulate the phenotype of ghrelin/GhrR KO mice. Antagonist treatment blocked ghrelin-induced and spontaneous food intake; however, the effects on spontaneous feeding were absent in GhrR KO mice, suggesting target-specific effects of the antagonists. Oral administration of antagonists to HFD-fed mice improved insulin sensitivity in both glucose tolerance and glycemic clamp tests. The insulin sensitivity observed was characterized by improved glucose disposal with dramatically decreased insulin secretion. It is noteworthy that these results mimic those obtained in similar tests of HFD-fed GhrR KO mice. HFD-fed mice treated for 56 days with antagonist experienced a transient decrease in food intake but a sustained body weight decrease resulting from decreased white adipose, but not lean tissue. They also had improved glucose disposal and a striking reduction in the amount of insulin needed to achieve this. These mice had reduced hepatic steatosis, improved liver function, and no evidence of systemic toxicity relative to controls. Furthermore, GhrR KO mice placed on low- or high-fat diets had lifespans similar to the wild type, emphasizing the long-term safety of ghrelin receptor blockade. We have therefore demonstrated that chronic pharmacologic blockade of the GhrR is an effective and safe strategy for treating metabolic syndrome.

Asunto(s)

Resistencia a la Insulina/fisiología , Insulina/metabolismo , Receptores de Ghrelina/antagonistas & inhibidores , Transducción de Señal/efectos de los fármacos , Animales , Fármacos Antiobesidad/farmacología , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Células CHO , Cricetinae , Cricetulus , Grasas de la Dieta/farmacología , Ingestión de Alimentos/efectos de los fármacos , Ghrelina/antagonistas & inhibidores , Ghrelina/farmacología , Técnica de Clampeo de la Glucosa , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Obesidad/tratamiento farmacológico , Receptores de Ghrelina/fisiología , Estrés Fisiológico/fisiología

RESUMEN

Identification of genes and pathways that alter lifespan has allowed for new insights into factors that control the aging process as well as disease. While strong molecular links exist between aging and metabolism, we hypothesize that targeting the mechanisms involved in aging will also give rise to therapeutics that treat other devastating age-related diseases, such as neurodegeneration, cancer, inflammation and cardiovascular disease. Insulin sensitivity, glycemic control and adiposity are not only hallmarks of the major metabolic diseases, type 2 diabetes and obesity, but they also represent significant risk factors for the development of Alzheimer's Disease and cognitive impairment. Insulin/IGF-1 signaling is an important pathway regulating aging and disease in a variety of species, including mammals. Here we describe an important role for the gut-derived peptide ghrelin in upstream signaling through the insulin/IGF-1 pathway and exemplify modulation of ghrelin signaling as an approach to mechanistic treatment of multiple age-related diseases by virtue of its ability to regulate key metabolic functions.

Asunto(s)

Adiposidad , Envejecimiento/fisiología , Glucemia , Resistencia a la Insulina , Longevidad/fisiología , Animales , Humanos

RESUMEN

Molecular genetics in lower organisms has allowed the elucidation of pathways that modulate the aging process. In certain instances, evolutionarily conserved genes and pathways have been shown to regulate lifespan in mammals as well. Many gene products known to affect lifespan are intimately involved in the control of energy metabolism, including the fuel sensor AMP-activated protein kinase (AMPK). We have shown previously that over-expression of an AMPK alpha subunit in Caenorhabditis elegans, designated aak-2, increases lifespan. Here we show the interaction of aak-2 with other pathways known to control aging in worms. Lifespan extension caused by daf-2/insulin-like signaling mutations was highly dependent on aak-2, as was the lifespan extension caused by over-expression of the deacetylase, sir-2.1. Similarly, there was partial requirement for aak-2 in lifespan extension by mitochondrial mutations (isp-1 and clk-1). Conversely, aak-2 was not required for lifespan extension in mutants lacking germline stem cells (glp-1) or mutants of the eating response (eat-2). These results show that aging is controlled by overlapping but distinct pathways and that AMPK/aak-2 represents a node in a network of evolutionarily conserved biochemical pathways that control aging.

Asunto(s)

Envejecimiento/fisiología , Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/enzimología , Caenorhabditis elegans/fisiología , Complejos Multienzimáticos/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Quinasas Activadas por AMP , Nucleótidos de Adenina/metabolismo , Animales , Caenorhabditis elegans/crecimiento & desarrollo , Conducta Alimentaria , Factores de Transcripción Forkhead , Regulación del Desarrollo de la Expresión Génica , Mutación de Línea Germinal/genética , Larva/crecimiento & desarrollo , Longevidad , Mitocondrias/metabolismo , Modelos Biológicos , Unión Proteica , Sirtuinas/metabolismo , Factores de Tiempo , Factores de Transcripción/metabolismo

RESUMEN

Human SIRT1 is an enzyme that deacetylates the p53 tumor suppressor protein and has been suggested to modulate p53-dependent functions including DNA damage-induced cell death. In this report, we used EX-527, a novel, potent, and specific small-molecule inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage. Treatment with EX-527 dramatically increased acetylation at lysine 382 of p53 after different types of DNA damage in primary human mammary epithelial cells and several cell lines. Significantly, inhibition of SIRT1 catalytic activity by EX-527 had no effect on cell growth, viability, or p53-controlled gene expression in cells treated with etoposide. Acetyl-p53 was also increased by the histone deacetylase (HDAC) class I/II inhibitor trichostatin A (TSA). EX-527 and TSA acted synergistically to increase acetyl-p53 levels, confirming that p53 acetylation is regulated by both SIRT1 and HDACs. While TSA alone reduced cell survival after DNA damage, the combination of EX-527 and TSA had no further effect on cell viability and growth. These results show that, although SIRT1 deacetylates p53, this does not play a role in cell survival following DNA damage in certain cell lines and primary human mammary epithelial cells.

Asunto(s)

Daño del ADN , Inhibidores de Histona Desacetilasas , Sirtuinas/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/metabolismo , Acetilación , Catálisis/efectos de los fármacos , Línea Celular , Supervivencia Celular , ADN/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Regulación de la Expresión Génica , Humanos , Ácidos Hidroxámicos/farmacología , Sirtuina 1

RESUMEN

High-throughput screening against the human sirtuin SIRT1 led to the discovery of a series of indoles as potent inhibitors that are selective for SIRT1 over other deacetylases and NAD-processing enzymes. The most potent compounds described herein inhibit SIRT1 with IC50 values of 60-100 nM, representing a 500-fold improvement over previously reported SIRT inhibitors. Preparation of enantiomerically pure indole derivatives allowed for their characterization in vitro and in vivo. Kinetic analyses suggest that these inhibitors bind after the release of nicotinamide from the enzyme and prevent the release of deacetylated peptide and O-acetyl-ADP-ribose, the products of enzyme-catalyzed deacetylation. These SIRT1 inhibitors are low molecular weight, cell-permeable, orally bioavailable, and metabolically stable. These compounds provide chemical tools to study the biology of SIRT1 and to explore therapeutic uses for SIRT1 inhibitors.

Asunto(s)

Carbazoles/síntesis química , Inhibidores de Histona Desacetilasas , Indoles/síntesis química , Sirtuinas/antagonistas & inhibidores , Animales , Disponibilidad Biológica , Células CHO , Carbazoles/química , Carbazoles/farmacología , Permeabilidad de la Membrana Celular , Cricetinae , Cricetulus , Estabilidad de Medicamentos , Fluorometría , Histona Desacetilasas/química , Humanos , Técnicas In Vitro , Indoles/química , Indoles/farmacología , Cinética , Ratones , Ratones Endogámicos C57BL , Microsomas Hepáticos/metabolismo , NAD/química , NAD+ Nucleosidasa/química , Niacinamida/química , Ratas , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/química , Sirtuina 1 , Sirtuinas/química , Estereoisomerismo , Relación Estructura-Actividad

RESUMEN

We describe a microplate-based assay for NAD-dependent Class III histone deacetylases (also known as SIRTs) that measures the enzyme-catalyzed release of nicotinamide from radiolabeled NAD, using a boronic acid resin to selectively capture the NAD. This method avoids the need for fluorogenic or radiolabeled peptides or separation of the reaction products using solvent extraction. The protocol reported here is rapid and uses commercially available materials. The use of a simple microplate filtration device allows for the simultaneous processing of 96 samples, facilitating enzyme kinetic analyses and inhibition studies. Furthermore, monitoring nicotinamide release rather than peptide deacetylation obviates the need for chemical modification of protein and peptide substrates. This assay is applicable to SIRTs and other enzymes that cleave nicotinamide from NAD.

Asunto(s)

Resinas Acrílicas/química , Ácidos Borónicos/química , NAD/metabolismo , Niacinamida/metabolismo , Sirtuinas/metabolismo , Animales , Radioisótopos de Carbono/química , Catálisis , Técnicas de Laboratorio Clínico , Filtración/métodos , Histona Desacetilasas/química , Histona Desacetilasas/metabolismo , Humanos , Hidrólisis , Cinética , Modelos Químicos , Estructura Molecular , NAD/química , Niacinamida/química , Sirtuinas/química

RESUMEN

There has recently been significant progress in our understanding of the mechanisms that regulate ageing, and it has been shown that changes in single genes can dramatically extend lifespan and increase resistance to many diseases. Furthermore, many of these genes belong to evolutionarily conserved pathways that also control energy metabolism. In this review, we describe the shared molecular machinery that regulates ageing and energy metabolism. Although drugs to slow ageing face severe regulatory hurdles, it is likely that an understanding of ageing pathways will help to identify novel drug targets to treat metabolic disorders and other age-related diseases.

Asunto(s)

Envejecimiento/efectos de los fármacos , Envejecimiento/fisiología , Diseño de Fármacos , Metabolismo/efectos de los fármacos , Metabolismo/fisiología , Proteínas Quinasas Activadas por AMP , Adipocitos/efectos de los fármacos , Envejecimiento/genética , Animales , Ingestión de Alimentos/fisiología , Humanos , Insulina/fisiología , Esperanza de Vida , Metabolismo/genética , Complejos Multienzimáticos/fisiología , Proteínas Serina-Treonina Quinasas/fisiología

RESUMEN

Resveratrol, a small molecule found in red wine, is reported to slow aging in simple eukaryotes and has been suggested as a potential calorie restriction mimetic. Resveratrol has also been reported to act as a sirtuin activator, and this property has been proposed to account for its anti-aging effects. We show here that resveratrol is a substrate-specific activator of yeast Sir2 and human SirT1. In particular, we observed that, in vitro, resveratrol enhances binding and deacetylation of peptide substrates that contain Fluor de Lys, a non-physiological fluorescent moiety, but has no effect on binding and deacetylation of acetylated peptides lacking the fluorophore. Consistent with these biochemical data we found that in three different yeast strain backgrounds, resveratrol has no detectable effect on Sir2 activity in vivo, as measured by rDNA recombination, transcriptional silencing near telomeres, and life span. In light of these findings, the mechanism accounting for putative longevity effects of resveratrol should be reexamined.

Asunto(s)

Antioxidantes/farmacología , Histona Desacetilasas/química , Sirtuinas/antagonistas & inhibidores , Sirtuinas/química , Estilbenos/farmacología , Unión Competitiva , ADN Ribosómico/química , ADN Ribosómico/metabolismo , Relación Dosis-Respuesta a Droga , Proteínas Fúngicas/química , Silenciador del Gen , Inhibidores de Histona Desacetilasas , Humanos , Técnicas In Vitro , Cinética , Modelos Químicos , Niacinamida/química , Péptidos/química , Unión Proteica , Recombinación Genética , Resveratrol , Proteínas Reguladoras de Información Silente de Saccharomyces cerevisiae/antagonistas & inhibidores , Proteínas Reguladoras de Información Silente de Saccharomyces cerevisiae/metabolismo , Sirtuina 1 , Sirtuina 2 , Especificidad por Sustrato , Telómero/metabolismo , Factores de Tiempo , Transcripción Genética , Proteína p53 Supresora de Tumor/metabolismo

RESUMEN

Although limiting energy availability extends lifespan in many organisms, it is not understood how lifespan is coupled to energy levels. We find that the AMP:ATP ratio, a measure of energy levels, increases with age in Caenorhabditis elegans and can be used to predict life expectancy. The C. elegans AMP-activated protein kinase alpha subunit AAK-2 is activated by AMP and functions to extend lifespan. In addition, either an environmental stressor that increases the AMP:ATP ratio or mutations that lower insulin-like signaling extend lifespan in an aak-2-dependent manner. Thus, AAK-2 is a sensor that couples lifespan to information about energy levels and insulin-like signals.

Asunto(s)

Adenosina Monofosfato/metabolismo , Envejecimiento/fisiología , Caenorhabditis elegans/fisiología , Longevidad/efectos de los fármacos , Complejos Multienzimáticos/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Transducción de Señal/fisiología , Proteínas Quinasas Activadas por AMP , Adenosina Trifosfato/metabolismo , Factores de Edad , Animales , Animales Modificados Genéticamente , Cruzamientos Genéticos , Cartilla de ADN , Metabolismo Energético/fisiología , Técnicas de Transferencia de Gen , Proteínas Fluorescentes Verdes , Inmunoprecipitación , Insulina/metabolismo , Complejos Multienzimáticos/genética , Mutagénesis , Proteínas Serina-Treonina Quinasas/genética , Análisis de Secuencia de ADN , Temperatura

RESUMEN

BACKGROUND: Voltage-gated sodium channels composed of pore-forming alpha and auxiliary beta subunits are responsible for the rising phase of the action potential in cardiac muscle, but their localizations have not yet been clearly defined. METHODS AND RESULTS: Immunocytochemical studies show that the principal cardiac alpha subunit isoform Na(v)1.5 and the beta2 subunit are preferentially localized in intercalated disks, identified by immunostaining of connexin 43, the major protein of cardiac gap junctions. The brain alpha subunit isoforms Na(v)1.1, Na(v)1.3, and Na(v)1.6 are preferentially localized with beta1 and beta3 subunits in the transverse tubules, identified by immunostaining of alpha-actinin, a cardiac z-line protein. The beta1 subunit is also present in a small fraction of intercalated disks. The recently cloned beta4 subunit, which closely resembles beta2 in amino acid sequence, is also expressed in ventricular myocytes and is localized in intercalated disks as are beta2 and Na(v)1.5. CONCLUSIONS: Our results suggest that the primary sodium channels present in ventricular myocytes are composed of Na(v)1.5 plus beta2 and/or beta4 subunits in intercalated disks and Na(v)1.1, Na(v)1.3, and Na(v)1.6 plus beta1 and/or beta3 subunits in the transverse tubules.

Asunto(s)

Miocitos Cardíacos/química , Proteínas del Tejido Nervioso/análisis , Canales de Sodio/análisis , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/análisis , Anticuerpos Monoclonales/inmunología , Células Cultivadas/química , Conexina 43/análisis , Ventrículos Cardíacos , Ratones , Microscopía Confocal , Microscopía Fluorescente , Datos de Secuencia Molecular , Miocitos Cardíacos/ultraestructura , Canal de Sodio Activado por Voltaje NAV1.1 , Orgánulos/química , Isoformas de Proteínas/análisis , Subunidades de Proteína/análisis , Fracciones Subcelulares/química , Transfección

RESUMEN

The principal alpha subunit of voltage-gated sodium channels is associated with auxiliary beta subunits that modify channel function and mediate protein-protein interactions. We have identified a new beta subunit termed beta4. Like the beta1-beta3 subunits, beta4 contains a cleaved signal sequence, an extracellular Ig-like fold, a transmembrane segment, and a short intracellular C-terminal tail. Using TaqMan reverse transcription-PCR analysis, in situ hybridization, and immunocytochemistry, we show that beta4 is widely distributed in neurons in the brain, spinal cord, and some sensory neurons.beta4 is most similar to the beta2 subunit (35% identity), and, like the beta2 subunit, the Ig-like fold of beta4 contains an unpaired cysteine that may interact with the alpha subunit. Under nonreducing conditions, beta4 has a molecular mass exceeding 250 kDa because of its covalent linkage to Nav1.2a, whereas on reduction, it migrates with a molecular mass of 38 kDa, similar to the mature glycosylated forms of the other beta subunits. Coexpression of beta4 with brain Nav1.2a and skeletal muscle Nav1.4 alpha subunits in tsA-201 cells resulted in a negative shift in the voltage dependence of channel activation, which overrode the opposite effects of beta1 and beta3 subunits when they were present. This novel, disulfide-linked beta subunit is likely to affect both protein-protein interactions and physiological function of multiple sodium channel alpha subunits.

Asunto(s)

Subunidades de Proteína/química , Subunidades de Proteína/fisiología , Canales de Sodio/química , Canales de Sodio/fisiología , Secuencia de Aminoácidos , Animales , Adhesión Celular , Línea Celular , Clonación Molecular , Disulfuros/química , Humanos , Masculino , Ratones , Datos de Secuencia Molecular , Canal de Sodio Activado por Voltaje NAV1.2 , Proteínas del Tejido Nervioso/metabolismo , Neuronas/metabolismo , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , ARN Mensajero/biosíntesis , Ratas , Ratas Sprague-Dawley , Análisis de Secuencia de Proteína , Homología de Secuencia de Aminoácido , Canales de Sodio/genética , Canales de Sodio/metabolismo , Distribución Tisular , Subunidad beta-2 de Canal de Sodio Activado por Voltaje , Subunidad beta-4 de Canal de Sodio Activado por Voltaje

RESUMEN

Transient receptor potential (TRP) proteins are cation-selective channels that function in processes as diverse as sensation and vasoregulation. Mammalian TRP channels that are gated by heat and capsaicin (>43 degrees C; TRPV1 (ref. 1)), noxious heat (>52 degrees C; TRPV2 (ref. 2)), and cooling (< 22 degrees C; TRPM8 (refs 3, 4)) have been cloned; however, little is known about the molecular determinants of temperature sensing in the range between approximately 22 degrees C and 40 degrees C. Here we have identified a member of the vanilloid channel family, human TRPV3 (hTRPV3) that is expressed in skin, tongue, dorsal root ganglion, trigeminal ganglion, spinal cord and brain. Increasing temperature from 22 degrees C to 40 degrees C in mammalian cells transfected with hTRPV3 elevated intracellular calcium by activating a nonselective cationic conductance. As in published recordings from sensory neurons, the current was steeply dependent on temperature, sensitized with repeated heating, and displayed a marked hysteresis on heating and cooling. On the basis of these properties, we propose that hTRPV3 is thermosensitive in the physiological range of temperatures between TRPM8 and TRPV1.

Asunto(s)

Calcio/metabolismo , Proteínas de Transporte de Catión , Permeabilidad de la Membrana Celular , Activación del Canal Iónico , Canales Iónicos/metabolismo , Temperatura , Secuencia de Aminoácidos , Animales , Células CHO , Señalización del Calcio , Cationes Bivalentes/metabolismo , Clonación Molecular , Cricetinae , Conductividad Eléctrica , Electrofisiología , Evolución Molecular , Perfilación de la Expresión Génica , Humanos , Canales Iónicos/química , Canales Iónicos/genética , Datos de Secuencia Molecular , Estructura Terciaria de Proteína , ARN Mensajero/genética , ARN Mensajero/metabolismo , Alineación de Secuencia , Canales Catiónicos TRPV

RESUMEN

The study of ion channel-mediated changes in membrane potential using the conventional bisoxonol fluorescent dye DiBAC(4)(3) has several limitations, including a slow onset of response and multistep preparation, that limit both the fidelity of the results and the throughput of membrane potential assays. Here, we report the characterization of the FLIPR Membrane Potential Assay Kit (FMP) in cells expressing voltage- and ligand-gated ion channels. The steady-state and kinetics fluorescence properties of FMP were compared with those of DiBAC(4)(3), using both FLIPR and whole-cell patch-clamp recording. Our experiments with the voltage-gated K(+) channel, hElk-1, revealed that FMP was 14-fold faster than DiBAC(4)(3) in response to depolarization. On addition of 60 mM KCl, the kinetics of fluorescence changes of FMP using FLIPR were identical to those observed in the electrophysiological studies using whole-cell current clamp. In addition, KCl concentration-dependent increases in FMP fluorescence correlated with the changes of membrane potential recorded in whole-cell patch clamp. In studies examining vanilloid receptor-1, a ligand-gated nonselective cation channel, FMP was superior to DiBAC(4)(3) with respect to both kinetics and amplitude of capsaicin-induced fluorescence changes. FMP has also been used to measure the activation of K(ATP) and hERG. Thus this novel membrane potential dye represents a powerful tool for developing high-throughput screening assays for ion channels.

Asunto(s)

Biotecnología/métodos , Membrana Celular/metabolismo , Colorantes Fluorescentes/farmacología , Canales Iónicos , Adenosina Trifosfato/metabolismo , Animales , Automatización , Células CHO , Cationes , Línea Celular , Cricetinae , Relación Dosis-Respuesta a Droga , Electrofisiología , Humanos , Cinética , Técnicas de Placa-Clamp , Potasio/metabolismo , Cloruro de Potasio/química , Espectrometría de Fluorescencia , Factores de Tiempo